Summary:
We are conducting a clinical trial to evaluate the efficacy and safety of Naldemedine for the treatment of constipation due to Opioid therapy (OIC) in subjects with non-malignant chronic pain.
Qualified Participants Must:
• Be between 19 and 80 years of age
•
Have non-malignant chronic pain that has been treated with opioids for at least three months and have OIC.
Must be otherwise healthy
Qualified Participants May Receive:
Compensation for time and travel.